FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291583316> ?p ?o ?g. }

• W4291583316 endingPage "1187" @default.
• W4291583316 startingPage "1187" @default.
• W4291583316 abstract "Importance Cerebral small vessel disease (SVD) causes a quarter of strokes and is the most common pathology underlying vascular cognitive impairment and dementia. An important step to developing new treatments is better trial methodology. Disease mechanisms in SVD differ from other stroke etiologies; therefore, treatments need to be evaluated in cohorts in which SVD has been well characterized. Furthermore, SVD itself can be caused by a number of different pathologies, the most common of which are arteriosclerosis and cerebral amyloid angiopathy. To date, there have been few sufficiently powered high-quality randomized clinical trials in SVD, and inconsistent trial methodology has made interpretation of some findings difficult. Observations To address these issues and develop guidelines for optimizing design of clinical trials in SVD, the Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE) was created under the auspices of the International Society of Vascular Behavioral and Cognitive Disorders. Experts in relevant aspects of SVD trial methodology were convened, and a structured Delphi consensus process was used to develop recommendations. Areas in which recommendations were developed included optimal choice of study populations, choice of clinical end points, use of brain imaging as a surrogate outcome measure, use of circulating biomarkers for participant selection and as surrogate markers, novel trial designs, and prioritization of therapeutic agents using genetic data via Mendelian randomization. Conclusions and Relevance The FINESSE provides recommendations for trial design in SVD for which there are currently few effective treatments. However, new insights into understanding disease pathogenesis, particularly from recent genetic studies, provide novel pathways that could be therapeutically targeted. In addition, whether other currently available cardiovascular interventions are specifically effective in SVD, as opposed to other subtypes of stroke, remains uncertain. FINESSE provides a framework for design of trials examining such therapeutic approaches." @default.
• W4291583316 created "2022-08-15" @default.
• W4291583316 creator A5004889443 @default.
• W4291583316 creator A5004976391 @default.
• W4291583316 creator A5014262891 @default.
• W4291583316 creator A5015783013 @default.
• W4291583316 creator A5018722034 @default.
• W4291583316 creator A5027568070 @default.
• W4291583316 creator A5028517821 @default.
• W4291583316 creator A5028587177 @default.
• W4291583316 creator A5032352602 @default.
• W4291583316 creator A5032387052 @default.
• W4291583316 creator A5036878734 @default.
• W4291583316 creator A5036911759 @default.
• W4291583316 creator A5040599069 @default.
• W4291583316 creator A5044380831 @default.
• W4291583316 creator A5047149331 @default.
• W4291583316 creator A5047177474 @default.
• W4291583316 creator A5049731912 @default.
• W4291583316 creator A5050427695 @default.
• W4291583316 creator A5053314544 @default.
• W4291583316 creator A5056940847 @default.
• W4291583316 creator A5061123357 @default.
• W4291583316 creator A5069738985 @default.
• W4291583316 creator A5071000616 @default.
• W4291583316 creator A5071006882 @default.
• W4291583316 creator A5073434872 @default.
• W4291583316 creator A5076932119 @default.
• W4291583316 creator A5083686989 @default.
• W4291583316 creator A5084656383 @default.
• W4291583316 creator A5086287565 @default.
• W4291583316 creator A5087289959 @default.
• W4291583316 creator A5088588603 @default.
• W4291583316 creator A5088937468 @default.
• W4291583316 date "2022-11-01" @default.
• W4291583316 modified "2023-10-18" @default.
• W4291583316 title "Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE)" @default.
• W4291583316 cites W1551254781 @default.
• W4291583316 cites W1565215438 @default.
• W4291583316 cites W1903499220 @default.
• W4291583316 cites W1926578487 @default.
• W4291583316 cites W1979492588 @default.
• W4291583316 cites W1982098412 @default.
• W4291583316 cites W2002667055 @default.
• W4291583316 cites W2003442589 @default.
• W4291583316 cites W2023658755 @default.
• W4291583316 cites W2035892177 @default.
• W4291583316 cites W2051164530 @default.
• W4291583316 cites W2051777375 @default.
• W4291583316 cites W2087649976 @default.
• W4291583316 cites W2107115040 @default.
• W4291583316 cites W2118410443 @default.
• W4291583316 cites W2124681501 @default.
• W4291583316 cites W2127553032 @default.
• W4291583316 cites W2138595885 @default.
• W4291583316 cites W2139395668 @default.
• W4291583316 cites W2141031417 @default.
• W4291583316 cites W2157032372 @default.
• W4291583316 cites W2158742097 @default.
• W4291583316 cites W2162420979 @default.
• W4291583316 cites W2164186760 @default.
• W4291583316 cites W2168477118 @default.
• W4291583316 cites W2314430530 @default.
• W4291583316 cites W2375395277 @default.
• W4291583316 cites W2517883070 @default.
• W4291583316 cites W2570315135 @default.
• W4291583316 cites W2612583120 @default.
• W4291583316 cites W2761952268 @default.
• W4291583316 cites W2763321580 @default.
• W4291583316 cites W2765657382 @default.
• W4291583316 cites W2792254568 @default.
• W4291583316 cites W2804939189 @default.
• W4291583316 cites W2805512903 @default.
• W4291583316 cites W2898320157 @default.
• W4291583316 cites W2912533302 @default.
• W4291583316 cites W2915777197 @default.
• W4291583316 cites W2938093040 @default.
• W4291583316 cites W2938846115 @default.
• W4291583316 cites W2942128643 @default.
• W4291583316 cites W2945933197 @default.
• W4291583316 cites W2967318538 @default.
• W4291583316 cites W2983623050 @default.
• W4291583316 cites W2991513719 @default.
• W4291583316 cites W2995245946 @default.
• W4291583316 cites W3002416957 @default.
• W4291583316 cites W3009939277 @default.
• W4291583316 cites W3015774024 @default.
• W4291583316 cites W3045997188 @default.
• W4291583316 cites W3081877184 @default.
• W4291583316 cites W3083583015 @default.
• W4291583316 cites W3099025086 @default.
• W4291583316 cites W3122108698 @default.
• W4291583316 cites W3122663351 @default.
• W4291583316 cites W3136867187 @default.
• W4291583316 cites W4200409424 @default.
• W4291583316 cites W4236639126 @default.
• W4291583316 cites W4244388228 @default.
• W4291583316 cites W4247665917 @default.

• next